Trials / Completed
CompletedNCT00229970
MK0476 Study in Adult Patients With Acute Asthma (0476-322)
MK0476 Phase II/III Placebo Controlled Double Blind Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 225 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 15 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the efficacy and safety of MK0476 intravenous administration in adult patients with acute asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast sodium | 7 mg or 14 mg single injection |
| DRUG | Comparator: Placebo | Placebo single injection |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2006-10-01
- Completion
- 2007-06-01
- First posted
- 2005-09-30
- Last updated
- 2022-02-02
- Results posted
- 2009-07-17
Source: ClinicalTrials.gov record NCT00229970. Inclusion in this directory is not an endorsement.